Leflunomide Medications

Leflunomide is a DMARD used to treat rheumatoid arthritis by suppressing immune cell proliferation.

Arava

Leflunomide

$1.54 per pill

10 | 20mg

Select pack

About Leflunomide

Leflunomide is an immunomodulatory disease-modifying antirheumatic drug (DMARD) approved for the treatment of moderate to severe rheumatoid arthritis and, in some jurisdictions, for psoriatic arthritis. Belonging to the class of pyrimidine synthesis inhibitors, it reduces the proliferation of activated lymphocytes that drive joint inflammation. The molecule works by blocking the enzyme dihydroorotate dehydrogenase, a key step in de novo pyrimidine synthesis, thereby limiting DNA synthesis in rapidly dividing immune cells. Marketed globally under brand names such as Arava, Lefumide, and Leflunomide-M, the drug is widely available in generic form, including through our online pharmacy. While the primary indication is rheumatoid arthritis, clinicians sometimes employ leflunomide off-label for conditions like juvenile idiopathic arthritis or certain vasculitides when standard therapies are insufficient. Its oral formulation, predictable pharmacokinetics, and once-daily dosing make it a convenient option for many patients, though careful monitoring is essential because of its safety profile.

What is Leflunomide?

Leflunomide is a synthetic, oral DMARD that interferes with the synthesis of pyrimidine nucleotides, thereby dampening the activity of immune cells involved in chronic inflammation. The Therapeutic Goods Administration (TGA) of Australia approved leflunomide in 1999 for adult rheumatoid arthritis, following earlier endorsement by the U.S. Food and Drug Administration (FDA) in 1998. Since then, the European Medicines Agency (EMA) has expanded its label to include psoriatic arthritis and, in some countries, juvenile idiopathic arthritis. Chemically, leflunomide is a pro-drug; after absorption it is rapidly converted to its active metabolite, teriflunomide, which selectively inhibits dihydroorotate dehydrogenase (DHODH). By targeting DHODH, leflunomide reduces the production of uridine-triphosphate, a building block necessary for DNA replication in activated T-cells and B-cells. The result is a slower, less aggressive immune response, translating into reduced joint swelling, pain, and structural damage. Generic leflunomide tablets are widely distributed, providing a cost-effective alternative to brand-name products.

How Leflunomide Works

Mechanism of Action

Leflunomide’s active metabolite, teriflunomide, binds to the ubiquinone-binding site of DHODH within the mitochondria of proliferating lymphocytes. This inhibition halts the de novo synthesis of pyrimidines, particularly uridine monophosphate, without markedly affecting salvage pathways in resting cells. Consequently, the drug selectively suppresses the expansion of activated T-cells and B-cells while sparing the majority of normal cellular function.

Therapeutic Effects

By curbing lymphocyte proliferation, leflunomide attenuates the cascade of cytokines-such as interleukin-1, interleukin-6, and tumor necrosis factor-α-that drive synovial inflammation. The net effect is decreased joint effusion, reduced cartilage degradation, and slower radiographic progression of erosive disease. Clinical observations also show modest improvements in patient-reported pain scores and physical function.

Onset and Duration

Therapeutic benefits typically emerge within 4-8 weeks of initiating treatment, although full clinical effect may require up to 6 months, especially in patients with longstanding disease. The half-life of teriflunomide is prolonged (approximately 2 weeks) due to extensive enterohepatic recirculation, allowing once-daily dosing. Steady-state concentrations are usually reached after 3 weeks of continuous therapy.

Approved Uses and Applications

Approved Indications

Rheumatoid arthritis (RA): For adults with active disease unresponsive to at least one conventional DMARD. The TGA and FDA label specify use as part of a combination regimen, often with methotrexate or low-dose glucocorticoids.
Psoriatic arthritis (PsA): Authorized in the European Union and Canada for patients with peripheral joint involvement who have inadequate response to prior DMARDs.
Juvenile idiopathic arthritis (JIA) - non-systemic polyarticular subtype: Approved in some European countries for patients aged 12 years and above when methotrexate is ineffective.

Off-Label Uses

Systemic vasculitis: Small observational cohorts indicate leflunomide may control disease activity when cyclophosphamide or biologics are contraindicated.
Multiple sclerosis (MS): Early-phase trials explored teriflunomide (the metabolite) as a disease-modifying agent, leading to the separate product aimed at MS, not leflunomide itself.
Transplant-related graft-versus-host disease: Limited case reports suggest benefit in steroid-refractory settings, though larger studies are lacking. These applications are not officially sanctioned by regulatory agencies.

Clinical Efficacy

Pivotal phase III trials, such as the Leflunomide Arthritis Study published in The New England Journal of Medicine (200), demonstrated a 30% greater ACR20 response (≥20% improvement in American College of Rheumatology criteria) compared with placebo after 24 weeks. Long-term extension data published in Arthritis & Rheumatology (2015) showed sustained remission rates of roughly 45% at 5 years among responders, with radiographic progression markedly slowed versus control groups. Comparative studies indicate leflunomide’s efficacy is roughly equivalent to methotrexate, while offering the convenience of oral administration without regular laboratory monitoring for hepatic enzyme levels beyond baseline checks.

Buying Leflunomide from Our Online Pharmacy

Why Choose Our Service

Access to leflunomide can be limited by regional stock shortages or insurance restrictions. Our service delivers a discreet, reliable supply directly to your door, ensuring you never miss a dose. By sourcing from licensed international pharmacies that meet WHO Good Manufacturing Practice standards, we maintain product integrity while offering lower prices than many brick-and-mortar providers.

Brand Names and Generic Options

Common brand names include Arava, Lefumide, and Leflunomide-M. Generic tablets, typically 10 mg, 20 mg, and 100 mg, are chemically identical and undergo the same stringent quality checks. Purchasing the generic version through our online pharmacy often reduces cost by up to 60% compared with brand-only options.

Quality & Safety

All shipments are fulfilled by partners accredited by the Australian Pharmacy Council and compliant with the TGA’s Imported Medicine Assurance Scheme. This framework guarantees that every batch is traceable, tested for purity, and stored under controlled conditions.

Pricing & Access

Our platform offers transparent pricing with no hidden fees. For example, a 30-day supply of 20 mg tablets costs AU$45 for the generic version, whereas the branded counterpart averages AU$120. Returning customers receive a lifetime 10 % discount on all reorders, making long-term therapy more affordable.

Discreet Delivery

Orders are packaged in plain, tamper-evident boxes to protect privacy. Express shipping delivers within ≈ 7 days for most Australian capitals, while standard service arrives in 3 weeks. Tracking information is provided at each stage of transit.

Dosing, Formulations & Administration

Available Formulations

Leflunomide is marketed primarily as oral tablets in strengths of 10 mg, 20 mg, and 100 mg. The drug is also supplied as a 100 mg tablet for rapid loading phases, though most clinicians start patients on lower doses to assess tolerance.

Typical Dosing Ranges

For adult rheumatoid arthritis, clinicians frequently begin with a loading dose of 100 mg once daily for the first 3 days, followed by a maintenance dose of 20 mg taken once daily. Adjustments may be made based on disease activity, hepatic function, and patient tolerability, with some protocols allowing reduction to 10 mg daily for sustained remission. In psoriatic arthritis, the same 20 mg maintenance dose is standard. Pediatric dosing for JIA, when approved, is weight-based (approximately 20 mg/m² per day), but exact amounts must be individualized.

Administration Guidelines

Leflunomide tablets should be swallowed whole with a full glass of water. Food does not significantly affect absorption, so dosing can be taken with or without meals. Because the drug’s active metabolite has a long half-life, clinicians may prescribe a cholestyramine washout (8 g three times daily for 11 days) if rapid discontinuation is required due to toxicity. Patients should avoid exposure to strong CYP450 inducers that could lower teriflunomide levels, though routine dose adjustments are rarely needed.

All dosing decisions must be made by a qualified healthcare provider after evaluating individual medical history, concomitant medications, and laboratory results.

Safety Profile & Considerations

Common Side Effects

Diarrhea: Reported in 10-15% of patients; usually mild and self-limiting.
Elevated liver enzymes (ALT/AST): Observed in 8-12% of users; baseline and periodic monitoring is recommended.
Hypertension: Occurs in roughly 7% of treated individuals; blood pressure checks are advised.
Hair thinning or loss: Aesthetic concern reported by about 5% of patients.
Nausea and abdominal pain: Present in up to 10% of cases, often transient during the loading phase.

Serious Adverse Events

Severe hepatotoxicity: Rare (≤1%) but can progress to hepatic failure; immediate cessation and evaluation are required if transaminases exceed 3-times the upper limit of normal.
Aplastic anemia and agranulocytosis: Extremely uncommon (<0.1%) but life-threatening; patients should report unexplained fatigue, bruising, or infections promptly.
Pregnancy-related teratogenicity: Strong evidence of fetal malformations; leflunomide is contraindicated in pregnancy and requires an accelerated elimination protocol before conception.

Contraindications

Known hypersensitivity to leflunomide or teriflunomide.
Severe hepatic impairment (Child-Pugh class C).
Pregnancy or planned pregnancy without appropriate washout.
Active infection requiring systemic therapy, as immunosuppression may exacerbate disease.

Drug Interactions

CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): May raise teriflunomide plasma levels, increasing toxicity risk.
Live vaccines: Contraindicated due to impaired immune response.
Warfarin: May potentiate anticoagulant effect; INR monitoring is advised.
Methotrexate: Co-administration is common but can enhance hepatotoxic potential; liver function should be closely followed.

Special Populations

Pregnancy: Mandatory discontinuation and cholestyramine washout before conception; contraception required during treatment and for at least 6 months after cessation.
Breastfeeding: Teriflunomide is excreted in milk; breastfeeding is not recommended.
Elderly: Age-related decline in hepatic function may necessitate lower starting doses and more frequent liver monitoring.
Renal or hepatic impairment: Dose reduction is advised; severe dysfunction is a contraindication.
Pediatric use: Reserved for adolescents meeting specific regulatory criteria; dosing is weight-adjusted and closely supervised.

Frequently Asked Questions

How does leflunomide differ from methotrexate? Both are conventional DMARDs, but leflunomide targets pyrimidine synthesis, whereas methotrexate inhibits folate metabolism. Leflunomide offers once-daily oral dosing without the need for folic acid supplementation, yet both have comparable efficacy in rheumatoid arthritis.
How long before leflunomide produces noticeable effects for rheumatoid arthritis? Patients often report symptom improvement within 4-8 weeks, but optimal disease control may take up to 6 months of continuous therapy.
What should I do if I experience mild diarrhea while taking leflunomide? Stay hydrated and monitor frequency. If diarrhea persists beyond a few days or is severe, contact your healthcare provider; dosage adjustment may be necessary.
Can I take leflunomide with food? Yes. Food does not significantly affect absorption, so the tablet can be taken with or without meals according to personal preference.
Is leflunomide safe for long-term use? Long-term safety data up to 5 years show stable liver enzyme profiles in most patients, provided regular monitoring is maintained. Rare serious events may still occur, underscoring the need for ongoing clinical oversight.
What foods should I avoid while on leflunomide? There are no specific dietary restrictions, but limiting alcohol intake helps reduce the risk of hepatic toxicity.
Does leflunomide interact with over-the-counter supplements? Herbal products that affect CYP3A4 (e.g., St John’s wort) can alter teriflunomide levels. Discuss any supplements with your clinician before starting therapy.
How is leflunomide cleared from the body if I need to stop it quickly? An accelerated elimination protocol using cholestyramine (8 g three times daily for 11 days) or biliary-acid sequestrants can reduce teriflunomide concentrations, facilitating faster drug clearance.
What information should I provide my doctor when discussing leflunomide?
- Complete list of current prescription and over-the-counter medications, including supplements.
- History of liver disease, hypertension, or renal impairment.
- Pregnancy status or plans for conception.
- Previous adverse reactions to DMARDs or biologic agents.
Can leflunomide be used in combination with biologic therapies? Some clinicians combine leflunomide with biologics like TNF inhibitors to achieve synergistic control, but infection risk rises and requires vigilant monitoring.

Disclaimer

The information provided about leflunomide is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing leflunomide for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing leflunomide.